Both the analysis of the different RBC parameters in ACTH-dependent and ACTH-independent CS subtypes (Fig. 3) and the analysis of the 32 CS patients without ACC and aggressive neuroendocrine neoplasms (19 CD, 7 ECS and 6 CPA) did not reveal any significant difference among the groups. This evidence concerns the gene POMC and Cowden syndrome 1.